Adverse respiratory effects of opioids for chronic breathlessness: to what extent can we learn lessons from chronic pain?
Eur Respir J
.
2018 Jul 19;52(1):1800882.
doi: 10.1183/13993003.00882-2018.
Print 2018 Jul.
Authors
Cornelia A Verberkt
1
,
Marieke H J van den Beuken-van Everdingen
2
,
Jos M G A Schols
3
4
,
Sushma Datla
5
,
Carmen D Dirksen
6
,
Miriam J Johnson
5
,
Sander M J van Kuijk
6
,
Emiel F M Wouters
7
8
,
Daisy J A Janssen
2
7
Affiliations
1
Dept of Health Services Research, Maastricht University, Maastricht, the Netherlands
[email protected]
.
2
Centre of Expertise for Palliative Care, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.
3
Dept of Health Services Research, Maastricht University, Maastricht, the Netherlands.
4
Dept of Family Medicine, Maastricht University, Maastricht, the Netherlands.
5
Hull York Medical School, University of Hull, Hull, UK.
6
Dept of Clinical Epidemiology and Medical Technology Assessment, MUMC+, Maastricht, the Netherlands.
7
CIRO, Centre of Expertise for Chronic Organ Failure, Horn, the Netherlands.
8
Dept of Respiratory Medicine, MUMC+, Maastricht, the Netherlands.
PMID:
30026306
DOI:
10.1183/13993003.00882-2018
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Analgesics, Opioid*
Chronic Pain
Dyspnea*
Humans
Morphine
Substances
Analgesics, Opioid
Morphine